Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Antibiotics|November 1, 1982
The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales)K Gerth, H Irschik, H Reichenbach, et al.
Archives of Microbiology|January 1, 1975
A new bacteriochlorophyll from brown-colored ChlorobiaceaeA Gloe, N Pfennig, H Brockmann, et al.
The Journal of Antibiotics|December 1, 1980
Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological propertiesK Gerth, H Irschik, H Reichenbach, et al.
The Journal of Antibiotics|December 1, 1980
Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). II. structure elucidationW Trowitzsch, G Reifenstahl, V Wray, et al.
The Journal of Antibiotics|February 1, 1992
Nannochelins A, B and C, new iron-chelating compounds from Nannocystis exedens (myxobacteria). Production, isolation, physico-chemical and biological propertiesB Kunze, W Trowitzsch-Kienast, G Höfle, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|September 4, 2001
Computer-aided design of novel siderophores: pyridinochelinM Meyer, R Schnurre, R Reissbrodt, et al.
The Journal of Antibiotics|July 1, 1989
Myxothiazol: a reversible blocker of the cell cycleP Conradt, K E Dittmar, H Schliephacke, et al.
The Journal of Antibiotics|August 1, 1988
Saframycin Mx1, a new natural saframycin isolated from a myxobacteriumH Irschik, W Trowitzsch-Kienast, K Gerth, et al.
Biochemistry|June 19, 1998
Solution structure of the cytoplasmic domain of the human CD4 glycoprotein by CD and 1H NMR spectroscopy: implications for biological functionsV Wray, D Mertins, M Kiess, et al.
European Journal of Biochemistry|January 15, 1994
Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductaseT Friedrich, P van Heek, H Leif, et al.
Pageof 1